CN113603693B - Preparation method of 2-bromo-5-p-toluenesulfonyl-5H-pyrrolo [2,3-b ] pyrazine - Google Patents

Preparation method of 2-bromo-5-p-toluenesulfonyl-5H-pyrrolo [2,3-b ] pyrazine Download PDF

Info

Publication number
CN113603693B
CN113603693B CN202110788968.5A CN202110788968A CN113603693B CN 113603693 B CN113603693 B CN 113603693B CN 202110788968 A CN202110788968 A CN 202110788968A CN 113603693 B CN113603693 B CN 113603693B
Authority
CN
China
Prior art keywords
toluenesulfonyl
pyrazine
pyrrolo
bromo
reaction system
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202110788968.5A
Other languages
Chinese (zh)
Other versions
CN113603693A (en
Inventor
郁慧
於长权
李明智
黄雨
庄玉江
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shaanxi Li Cai Pharmaceutical Co ltd
Original Assignee
Shaanxi Li Cai Pharmaceutical Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shaanxi Li Cai Pharmaceutical Co ltd filed Critical Shaanxi Li Cai Pharmaceutical Co ltd
Priority to CN202110788968.5A priority Critical patent/CN113603693B/en
Publication of CN113603693A publication Critical patent/CN113603693A/en
Application granted granted Critical
Publication of CN113603693B publication Critical patent/CN113603693B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Abstract

The invention comprises the following steps: dissolving 3- [ (trimethylsilyl) ethynyl ] -5-pyrazine-2-amine in a solvent N, N-dimethylacetamide, adding a mild alkali reagent, and reacting for 0.5-2 hours after heating; cooling the reaction system to room temperature, adding paratoluensulfonyl chloride, cooling the reaction system to room temperature, and reacting the reaction system at room temperature for 0.5-2 h; and step three, adding the mixture into 0.5-10% wt sodium bicarbonate water solution, filtering, recrystallizing, filtering and drying to obtain a finished product of the 2-bromo-5-p-toluenesulfonyl-5H-pyrrolo [2,3-b ] pyrazine. The invention uses the sodium tert-butoxide and other mild alkaline reagents, and improves the purification mode; the reaction condition is mild and controllable, and the by-products in the reaction process are less; and the operation and the post-treatment are simple, the product yield and the quality are obviously improved, the production time and the cost can be saved, and the method is suitable for industrial production.

Description

Preparation method of 2-bromo-5-p-toluenesulfonyl-5H-pyrrolo [2,3-b ] pyrazine
Technical Field
The invention relates to the field of chemical industry, in particular to a preparation method of 2-bromo-5-p-toluenesulfonyl-5H-pyrrolo [2,3-b ] pyrazine.
Background
2-bromine-5-p-toluenesulfonyl-5H-pyrrolo [2,3-b ] pyrazine is an important fine chemical raw material and a medical intermediate, CAS number is 1201186-54-0, molecular formula is C13H10BrN3O2S, and molecular structure is as follows:
Figure BDA0003160300400000011
the existing preparation process of the 2-bromo-5-p-toluenesulfonyl-5H-pyrrolo [2,3-b ] pyrazine has high risk, needs a dangerous sodium hydride reagent, has more byproducts, low product yield and long production time, and improves the production cost because the product needs to be purified by silica gel column chromatography. Therefore, a preparation method of 2-bromo-5-p-toluenesulfonyl-5H-pyrrolo [2,3-b ] pyrazine is needed to be designed.
Disclosure of Invention
Aiming at the defects of the prior art, the preparation method of the 2-bromo-5-p-toluenesulfonyl-5H-pyrrolo [2,3-b ] pyrazine is provided.
The invention is realized by the following scheme:
a method for preparing 2-bromo-5-p-toluenesulfonyl-5H-pyrrolo [2,3-b ] pyrazine, comprising the steps of:
dissolving 3- [ (trimethylsilyl) ethynyl ] -5-pyrazine-2-amine in a solvent N, N-dimethylacetamide, adding a mild alkali reagent, and reacting for 0.5-2h after heating;
cooling the reaction system to room temperature, adding paratoluensulfonyl chloride, cooling the reaction system to room temperature, and reacting the reaction system at room temperature for 0.5-2 h;
and step three, after the reaction is finished, adding the reaction system obtained in the step two into 0.5-10% wt of sodium bicarbonate water solution, filtering, adding the obtained solid filter cake into a mixed solvent, recrystallizing, filtering and drying to obtain a finished product of the 2-bromo-5-p-toluenesulfonyl-5H-pyrrolo [2,3-b ] pyrazine.
In the first step, the temperature is raised to 40-100 ℃ and then the reaction is carried out.
In the first step, the alkali reagent is one or more of sodium tert-butoxide, potassium tert-butoxide, lithium tert-butoxide, magnesium tert-butoxide, potassium carbonate, sodium carbonate, cesium carbonate, sodium bicarbonate and potassium bicarbonate; in step one, the added alkaline reagent: the molar ratio of 3- [ (trimethylsilyl) ethynyl ] -5-pyrazin-2-amine is 1.0-1.5: 1.0.
in the second step, the molar ratio of the added p-toluenesulfonyl chloride to the 3- [ (trimethylsilyl) ethynyl ] -5-pyrazine-2-amine added in the first step is 1.0-1.5: 1.0.
in the third step, the mixed solvent is one or more of aliphatic hydrocarbon, aromatic hydrocarbon, ether, ester and nitrile.
The beneficial effects of the invention are as follows:
compared with the sodium hydride reported in the literature as the alkali reagent, the preparation method of the 2-bromo-5-p-toluenesulfonyl-5H-pyrrolo [2,3-b ] pyrazine uses the mild alkali reagent such as sodium tert-butoxide and improves the purification mode in the preparation process. The reaction condition is mild and controllable, and the byproducts in the reaction process are less. And the operation and the post-treatment are simple, the product yield and the quality are obviously improved, the production time and the cost can be saved, and the method is suitable for industrial production.
Drawings
FIG. 1 is a 1HNMR map of 2-bromo-5-p-toluenesulfonyl-5H-pyrrolo [2,3-b ] pyrazine of the present invention;
FIG. 2 is a 13C NMR chart of 2-bromo-5-p-toluenesulfonyl-5H-pyrrolo [2,3-b ] pyrazine of the present invention.
Detailed Description
The following further illustrates preferred embodiments of the invention:
a method for preparing 2-bromo-5-p-toluenesulfonyl-5H-pyrrolo [2,3-b ] pyrazine, comprising the steps of:
dissolving 3- [ (trimethylsilyl) ethynyl ] -5-pyrazine-2-amine in a solvent N, N-dimethylacetamide, adding a mild alkali reagent, and reacting for 0.5-2h after heating;
cooling the reaction system to room temperature, adding paratoluensulfonyl chloride, cooling the reaction system to room temperature, and reacting the reaction system at room temperature for 0.5-2 h;
and step three, after the reaction is finished, adding the reaction system obtained in the step two into 0.5-10% wt sodium bicarbonate water solution, filtering, adding the obtained solid filter cake into a mixed solvent, recrystallizing, filtering and drying to obtain a finished product of the 2-bromo-5-p-toluenesulfonyl-5H-pyrrolo [2,3-b ] pyrazine.
In the first step, the temperature is raised to 40-100 ℃ and then the reaction is carried out.
In the first step, the alkali reagent is one or more of sodium tert-butoxide, potassium tert-butoxide, lithium tert-butoxide, magnesium tert-butoxide, potassium carbonate, sodium carbonate, cesium carbonate, sodium bicarbonate and potassium bicarbonate; in step one, the added alkaline reagent: the molar ratio of 3- [ (trimethylsilyl) ethynyl ] -5-pyrazin-2-amine is 1.0-1.5: 1.0.
in the second step, the molar ratio of the added p-toluenesulfonyl chloride to the 3- [ (trimethylsilyl) ethynyl ] -5-pyrazine-2-amine added in the first step is 1.0-1.5: 1.0.
in the third step, the mixed solvent is one or more of aliphatic hydrocarbon, aromatic hydrocarbon, ether, ester and nitrile.
The technical solution of the present application is further described below with reference to specific embodiments of the present application:
example 1
A preparation method of 2-bromo-5-p-toluenesulfonyl-5H-pyrrolo [2,3-b ] pyrazine comprises the following steps: adding N, N-dimethylacetamide (500ml), 3- [ (trimethylsilyl) ethynyl ] -5-pyrazine-2-amine (50.0g, 0.185mol) into a reaction kettle, adding sodium tert-butoxide (19.5g, 0.204mol), heating the reaction system to 90-100 ℃, reacting for 0.5h, cooling the reaction system to room temperature, adding p-toluenesulfonyl chloride (42.3g, 0.221mol), cooling the reaction system to room temperature, and reacting the reaction system at room temperature for 0.5 h. After the reaction is finished, pouring the reaction system into 2% wt sodium bicarbonate water solution, filtering, adding the obtained solid filter cake into mixed solvent ethyl acetate/petroleum ether for recrystallization, filtering and drying to obtain 55.1g of 2-bromo-5-p-toluenesulfonyl-5H-pyrrolo [2,3-b ] pyrazine with the molar yield of 84.5%.
Example 2
A preparation method of 2-bromo-5-p-toluenesulfonyl-5H-pyrrolo [2,3-b ] pyrazine comprises the following steps: adding N, N-dimethylacetamide (500ml) and 3- [ (trimethylsilyl) ethynyl ] -5-pyrazine-2-amine (50.0g and 0.185mol) into a reaction kettle, adding sodium tert-butoxide (21.3g and 0.221mol), heating the reaction system to 50-60 ℃, reacting for 1h, cooling the reaction system to room temperature, adding p-toluenesulfonyl chloride (45.8g and 0.240mol), cooling the reaction system to room temperature, and reacting the reaction system at room temperature for 1 h. After the reaction is finished, pouring the reaction system into a 5% wt sodium bicarbonate aqueous solution, filtering, adding the obtained solid filter cake into a mixed solvent of ethyl acetate/petroleum ether for recrystallization, filtering and drying to obtain 56.7g of 2-bromo-5-p-toluenesulfonyl-5H-pyrrolo [2,3-b ] pyrazine with the molar yield of 86.9%.
Example 3
A preparation method of 2-bromo-5-p-toluenesulfonyl-5H-pyrrolo [2,3-b ] pyrazine comprises the following steps: adding N, N-dimethylacetamide (500ml) and 3- [ (trimethylsilyl) ethynyl ] -5-pyrazine-2-amine (50.0g and 0.185mol) into a reaction kettle, adding sodium tert-butoxide (17.7g and 0.185mol), heating the reaction system to 40-50 ℃, reacting for 2h, cooling the reaction system to room temperature, adding p-toluenesulfonyl chloride (37.0g and 0.194mol), cooling the reaction system to room temperature, and reacting the reaction system at room temperature for 2 h. After the reaction is finished, pouring the reaction system into 3% wt sodium bicarbonate water solution, filtering, adding the obtained solid filter cake into mixed solvent ethyl acetate/petroleum ether for recrystallization, filtering and drying to obtain 54.4g of 2-bromo-5-p-toluenesulfonyl-5H-pyrrolo [2,3-b ] pyrazine with the molar yield of 83.4%.
FIG. 1 is a 1HNMR map of 2-bromo-5-p-toluenesulfonyl-5H-pyrrolo [2,3-b ] pyrazine of the present invention, and FIG. 2 is a 13CNMR map of 2-bromo-5-p-toluenesulfonyl-5H-pyrrolo [2,3-b ] pyrazine of the present invention.
As can be seen from FIGS. 1 and 2, the structure was confirmed by nuclear magnetic resonance spectroscopy (1H-NMR and 13C-NMR) and LC-MS.
And (3) detecting a hydrogen spectrum result of the sample: 1H-NMR (600MHz, CDCl 3). delta.2.41 (s, -CH3, 3H),6.79(s, -CH, 1H), 7.34(d, -C (CH)2, 2H),8.03(d, -C (CH)2, 2H)8.06(s, -CH, 1H), 8.43(s, -CH, 1H).
Carbon spectrum results: 13C-NMR (600MHz, CDCl3)
δ:21.71;105.67;128.16;130.03;131.60;134.58;136.12;139.21;140.28;141.94;14 6.20。
The assignment of nuclear magnetic resonance spectral shifts for 1H-NMR and 13C-NMR supports the structural features of the compounds. The structure is proved to be consistent with the structure of the compound 2-bromo-5-p-toluenesulfonyl-5H-pyrrolopyrazine in the combination of mass spectrum test results MS (ESI) m/z: 354.18.
The preparation method of 2-bromo-5-p-toluenesulfonyl-5H-pyrrolo [2,3-b ] pyrazine provided by the invention solves the problems of high risk, long production time, more byproducts and difficult purification of the prior art. The reaction uses mild alkaline reagents such as sodium tert-butoxide, reduces the risk of the preparation process, has few byproducts, obviously improves the product yield, has short production period, is convenient for product purification, reduces the production cost, and is suitable for large-scale industrial production.
Although the invention has been described and illustrated in some detail, it should be understood that various modifications may be made to the described embodiments or equivalents may be substituted, as will be apparent to those skilled in the art, without departing from the spirit of the invention.

Claims (4)

1. A method for preparing 2-bromo-5-p-toluenesulfonyl-5H-pyrrolo [2,3-b ] pyrazine is characterized by comprising the following steps:
dissolving 3- [ (trimethylsilyl) ethynyl ] -5-bromopyrazine-2-amine in a solvent N, N-dimethylacetamide, adding an alkali reagent, and reacting for 0.5-2h after heating;
cooling the reaction system to room temperature, adding p-toluenesulfonyl chloride, cooling the reaction system to room temperature, and reacting the reaction system at room temperature for 0.5-2 h;
step three, after the reaction is finished, adding the reaction system obtained in the step two into 0.5-10% wt of sodium bicarbonate water solution, filtering, adding the obtained solid filter cake into a mixed solvent, recrystallizing, filtering and drying to obtain a finished product of 2-bromo-5-p-toluenesulfonyl-5H-pyrrolo [2,3-b ] pyrazine;
in the first step, the alkali reagent is one or more of sodium tert-butoxide, potassium tert-butoxide, lithium tert-butoxide, magnesium tert-butoxide, potassium carbonate, sodium carbonate, cesium carbonate, sodium bicarbonate and potassium bicarbonate; in step one, the added alkaline reagent: the molar ratio of 3- [ (trimethylsilyl) ethynyl ] -5-bromopyrazine-2-amine is 1.0-1.5: 1.0.
2. the process for preparing 2-bromo-5-p-toluenesulfonyl-5H-pyrrolo [2,3-b ] pyrazine according to claim 1 wherein: in the first step, the temperature is raised to 40-100 ℃ and then the reaction is carried out.
3. The process for preparing 2-bromo-5-p-toluenesulfonyl-5H-pyrrolo [2,3-b ] pyrazine according to claim 1 wherein: in the second step, the molar ratio of the added p-toluenesulfonyl chloride to the 3- [ (trimethylsilyl) ethynyl ] -5-bromopyrazine-2-amine added in the first step is 1.0-1.5: 1.0.
4. the process for preparing 2-bromo-5-p-toluenesulfonyl-5H-pyrrolo [2,3-b ] pyrazine according to claim 1 wherein: in the third step, the mixed solvent is one or more of aliphatic hydrocarbon, aromatic hydrocarbon, ether, ester and nitrile.
CN202110788968.5A 2021-07-13 2021-07-13 Preparation method of 2-bromo-5-p-toluenesulfonyl-5H-pyrrolo [2,3-b ] pyrazine Active CN113603693B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202110788968.5A CN113603693B (en) 2021-07-13 2021-07-13 Preparation method of 2-bromo-5-p-toluenesulfonyl-5H-pyrrolo [2,3-b ] pyrazine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202110788968.5A CN113603693B (en) 2021-07-13 2021-07-13 Preparation method of 2-bromo-5-p-toluenesulfonyl-5H-pyrrolo [2,3-b ] pyrazine

Publications (2)

Publication Number Publication Date
CN113603693A CN113603693A (en) 2021-11-05
CN113603693B true CN113603693B (en) 2022-08-26

Family

ID=78304531

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202110788968.5A Active CN113603693B (en) 2021-07-13 2021-07-13 Preparation method of 2-bromo-5-p-toluenesulfonyl-5H-pyrrolo [2,3-b ] pyrazine

Country Status (1)

Country Link
CN (1) CN113603693B (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA106045C2 (en) * 2008-06-10 2014-07-25 Еббві Інк. Tricyclic compounds
CN102711476B (en) * 2009-12-01 2014-12-03 Abbvie公司 Novel tricyclic compounds
US10987354B2 (en) * 2016-12-15 2021-04-27 Sunshine Lake Pharma Co., Ltd. Inhibitors of influenza virus replication and uses thereof
WO2019057103A1 (en) * 2017-09-21 2019-03-28 上海华汇拓医药科技有限公司 Jak inhibitor, preparation method therefor, and application in the field of medicine
CN110117285B (en) * 2018-02-07 2023-02-03 广东东阳光药业有限公司 Inhibitors of influenza virus replication and uses thereof

Also Published As

Publication number Publication date
CN113603693A (en) 2021-11-05

Similar Documents

Publication Publication Date Title
CN112898192B (en) Preparation method of N-acyl indole compound
CN112979400A (en) Method for preparing 2-iodo aryl ether under action of alkali metal hydride
CN111704573A (en) Preparation method of rabeprazole chloride and intermediate thereof
CN114315759A (en) Preparation method of 2-methyl-1- (4-morpholinylphenyl) -2-morpholinyl-1-acetone
CN113603693B (en) Preparation method of 2-bromo-5-p-toluenesulfonyl-5H-pyrrolo [2,3-b ] pyrazine
CN115772157A (en) Preparation method of 2-alkoxy indole compound
JP6452575B2 (en) Manufacturing method of mirtazapine
CN109824661B (en) Preparation method of impurities in penehyclidine hydrochloride
CN111217709A (en) Preparation method of (1-fluorocyclopropyl) methylamine hydrochloride
JP2023548914A (en) Pyrrolinone compounds and their synthesis method
CN113087669B (en) Preparation method of 4-cyano-5-bromopyrimidine
CN114644629B (en) Synthesis method of [1,2,4] triazolo [1,5-a ] pyridine compound
CN114539020B (en) Preparation method of 1, 5-dibromo-3, 3-difluoropentane
CN111333528B (en) Synthesis method of multi-configuration O-phenyl-serine compound
CN108997340B (en) Synthetic method of 5-bromo-7-azaindole
CN114213261B (en) Preparation method of 4-methoxy-2-nitroaniline
CN112574133B (en) Synthesis method of 1, 3-diaryl substituted tetrazolone inner salt
CN112409288B (en) Method for synthesizing loxapine
CN106916103B (en) Preparation method of 2-phenylquinoline compound
CN110015996B (en) Method for synthesizing 2' -spiro-substituted ternary carbocyclic nucleoside
CN111995569B (en) Preparation method of cyclin-dependent kinase inhibitor intermediate
JP2004506628A (en) Intermediates for use in preparing vitamin E
CN115894503A (en) Preparation method of azacyclopentane derivative
CN117865881A (en) Preparation method of arbeli intermediate
CN115322106A (en) Synthesis method of trans-3-azido-1-methylcyclobutanol and trans-3-amino-1-methylcyclobutanol

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant